comparemela.com

Latest Breaking News On - Annual needham virtual healthcare conference - Page 5 : comparemela.com

Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

BRISBANE, Calif., April 03, 2024 Annexon, Inc. , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical.

Joyce allaireSheryl seapyLifesci advisorsAnnexon incDouglas loveAnnual needham virtual healthcare conferenceSci advisors

Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024 at 8:45 a.m. ET. The webcast of the presentation will b

United kingdomCorporate communicationsBill lundbergChief executive officerAnnual needham virtual healthcare conferenceMedia inquiriesCorp commsBill lundbergHealthcare conference

Merus N V : Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Merus N V : Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomDennis riedlXand linkedinBill lundbergChief executive officerAnnual needham virtual healthcare conference

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

LONDON, April 03, 2024 Mereo BioPharma Group plc , a clinical-stage biopharmaceutical company focused on rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer,.

United statesCity ofUnited kingdomMereo biopharmaLee rothChristine foxDenise scots knightExchange commissionMereo biopharma groupUltragenyx pharmaceutical incUnited states securities exchangeBiopharma groupChief executive officerFireside chatAnnual needham virtual healthcare conferenceUltragenyx pharmaceutical

P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference

P3 Health Partners Inc. , a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the 23rd Annual Needham Virtual.

Health partners incHealth partnersAnnual needham virtual healthcare conferenceRelations website

vimarsana © 2020. All Rights Reserved.